HAMILTON, Ontario, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to welcome the appointment of two new directors to its Board.
Alexander Nuttall joins the Board as an independent non-executive director and Chris Shields, the Company’s interim CEO, has also been appointed as a director.
Alexander Nuttall
Alex Nuttall currently serves as Mayor of Barrie and a Director on the Board of Alectra Utilities. First elected as a City Councillor in Barrie, in 2006, Alex continued to serve at the Municipal level of government until 2014. In 2015, Mayor Nuttall was elected as the Member of Parliament for Barrie-Springwater-Oro-Medonte. Alex served as Shadow Minister for numerous ministries: Digital Economy, Economic Development for Southern Ontario, Innovation, Science and Technology (Deputy), Youth Sports & Persons with Disabilities, and Interprovincial Trade. Prior to entering federal politics, Alex worked in the retail and commercial finance industry with TD, RBC and Meridian Credit Union. Following leaving federal politics in 2019, Alex served as Vice-President for Telecom North Frontenac Telephone Company overseeing the Sales, Marketing and Customer Service expansions.
Chris Shields
Chris Shields was recently appointed as Interim CEO of the Company, as announced on December 11, 2023. Mr. Shields currently handles the Company’s US business development and is very familiar with the operations and processes of the Company. Additionally, Mr. Shields has over 30 years of experience in the healthcare space and has held senior executive positions in start-ups and Fortune 500 companies. Based in Boston, MA, Mr. Shields has extensive experience with the US healthcare system and is widely regarded as a Medicare and Medicaid subject matter expert. He holds a Bachelor’s degree in Chemical Engineering from the University of Massachusetts, Lowell and an MBA specializing in Finance from Babson College in Wellesley, MA. Mr. Shields will lead the Company’s search for a permanent CEO.
“We are pleased to welcome Alex and Chris as new directors,” said Brian Storseth, director of the Company. “Both members bring a wide range of professional experience and valuable perspectives that will be integral as the Company continues to move forward”.
Reliq Health
Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN: A2AJTB.
ON BEHALF OF THE BOARD
“Chris Shields”
Interim CEO
For further information please contact:
Company Contact
Investor Relations at ir@reliqhealth.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
